• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无功能垂体腺瘤的性别相关差异。

Gender-related differences in non-functioning pituitary adenomas.

作者信息

Schaller Bernhard

机构信息

Department of Neurology, Freiburgstrasse 10, CH-3010 Berne, Switzerland.

出版信息

Neuro Endocrinol Lett. 2003 Dec;24(6):425-30.

PMID:15073569
Abstract

OBJECTIVES

Clinically non-functioning pituitary adenomas are common tumors of the pituitary gland. No studies have yet documented gender-related differences in the growth and presentation of these tumors and nothing is known about their effects on their subsequent surgical outcome and prognosis.

SETTING AND DESIGN

Twenty-eight patients with non-functioning pituitary adenoma, that met strict inclusion criteria, and that underwent surgical treatment between January 1990 and June 1997, were retrospectively reviewed.

METHODS

The patient charts, as well as histological (incl. immunohistochemistry) and electron microscopic findings were analyzed. Tumor invasiveness was classified according to the modified Hardy criteria.

MAIN FINDINGS

Eleven patients were women and seventeen were men; the female-to-male-ratio was 1:1.5. Men were significantly older, both at diagnosis and surgery. Visual field defect and visual acuity deficit were the most common presenting symptoms with similar occurrence both in women and men, whereas blindness predominated in women. Microadenomas and invasive adenomas did not differ significantly in MIB-1 index, but patients less than 35 years old had higher MIB-1 indices (n=4, 1.72+/-1.15), than did patients over 45 years (n=11, 0.63+/-0.42) (p: n.s.). MIB-1 labeling indices were higher in adenomas of female compared to male patients (1.5 +/-1.2 vs. 0.8+/-1.8; p < 0.003). The overall outcome was significantly worse in women than in men.

CONCLUSION

The biology and the clinical course of clinically non-functioning pituitary adenoma seem to differ in women and men. In men, tumors are smaller and less invasive at surgery, and the outcome is better than in women. The present findings may justify a more aggressive therapeutic approach to clinically non-functioning pituitary adenomas in women than in men, especially to improve the availability of viable pituitary cells at the time of surgery.

摘要

目的

临床无功能垂体腺瘤是垂体常见肿瘤。尚无研究记录这些肿瘤在生长和表现方面的性别差异,对其对后续手术结果和预后的影响也一无所知。

背景与设计

回顾性分析了1990年1月至1997年6月间28例符合严格纳入标准并接受手术治疗的无功能垂体腺瘤患者。

方法

分析患者病历以及组织学(包括免疫组化)和电子显微镜检查结果。根据改良的Hardy标准对肿瘤侵袭性进行分类。

主要发现

11例为女性,17例为男性;男女比例为1:1.5。男性在诊断和手术时年龄显著更大。视野缺损和视力减退是最常见的首发症状,在女性和男性中发生率相似,而失明在女性中更为常见。微腺瘤和侵袭性腺瘤的MIB-1指数无显著差异,但35岁以下患者的MIB-1指数(n = 4,1.72±1.15)高于45岁以上患者(n = 11,0.63±0.42)(p:无统计学意义)。女性患者腺瘤的MIB-1标记指数高于男性患者(1.5±1.2 vs. 0.8±1.8;p < 0.003)。女性的总体预后明显比男性差。

结论

临床无功能垂体腺瘤的生物学特性和临床病程在女性和男性中似乎有所不同。在男性中,肿瘤在手术时较小且侵袭性较低,结果比女性好。目前的发现可能证明对女性临床无功能垂体腺瘤采取比男性更积极的治疗方法是合理的,特别是为了提高手术时存活垂体细胞的可得性。

相似文献

1
Gender-related differences in non-functioning pituitary adenomas.无功能垂体腺瘤的性别相关差异。
Neuro Endocrinol Lett. 2003 Dec;24(6):425-30.
2
Gender-related differences in prolactinomas. A clinicopathological study.催乳素瘤的性别相关差异。一项临床病理研究。
Neuro Endocrinol Lett. 2005 Apr;26(2):152-9.
3
Fully endoscopic transsphenoidal surgery for functioning pituitary adenomas: a retrospective comparison with traditional transsphenoidal microsurgery in the same institution.功能性垂体腺瘤的全内镜经蝶窦手术:与同一机构传统经蝶窦显微手术的回顾性比较
Surg Neurol. 2009 Oct;72(4):336-40. doi: 10.1016/j.surneu.2009.04.012. Epub 2009 Jul 14.
4
Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.无功能(静止性)垂体腺瘤的临床肿瘤生长及其与增殖标志物的比较
Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):80-5. doi: 10.1055/s-2007-991131. Epub 2007 Dec 10.
5
[The natural course of non-functioning pituitary adenomas].[无功能垂体腺瘤的自然病程]
Ned Tijdschr Geneeskd. 2008 Nov 22;152(47):2537-43.
6
Expression of cell proliferation markers in pituitary adenomas--correlation and clinical relevance of MIB-1 and anti-topoisomerase-IIalpha.垂体腺瘤中细胞增殖标志物的表达——MIB-1与抗拓扑异构酶-IIα的相关性及临床意义
Acta Neurochir (Wien). 2004 Aug;146(8):831-9. doi: 10.1007/s00701-004-0298-0. Epub 2004 Jun 14.
7
Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.内镜经蝶窦治疗复发性和残留性垂体腺瘤——初步经验
Minim Invasive Neurosurg. 2006 Feb;49(1):10-4. doi: 10.1055/s-2006-932126.
8
Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.垂体腺瘤和癌中拓扑异构酶IIα的表达:与肿瘤行为的关系。
Mod Pathol. 2002 Nov;15(11):1205-12. doi: 10.1097/01.MP.0000036342.73003.55.
9
Pathobiology of pituitary adenomas and carcinomas.垂体腺瘤与癌的病理生物学
Neurosurgery. 2006 Aug;59(2):341-53; discussion 341-53. doi: 10.1227/01.NEU.0000223437.51435.6E.
10
Gender-related differences in growth hormone-releasing pituitary adenomas. A clinicopathological study.生长激素释放型垂体腺瘤的性别相关差异。一项临床病理研究。
Pituitary. 2002;5(4):247-53. doi: 10.1023/a:1025329900839.

引用本文的文献

1
Influence of gender and sexual hormones on outcomes after pituitary surgery: a systematic review and meta-analysis.性别和性激素对垂体手术后结局的影响:系统评价和荟萃分析。
Acta Neurochir (Wien). 2023 Sep;165(9):2445-2460. doi: 10.1007/s00701-023-05726-z. Epub 2023 Aug 9.
2
Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival.胸苷酸合成酶加速 Men1 介导的胰腺肿瘤进展并降低存活率。
JCI Insight. 2022 Oct 10;7(19):e147417. doi: 10.1172/jci.insight.147417.
3
Is there any gender difference in epidemiology, clinical presentation and co-morbidities of non-functioning pituitary adenomas? A prospective survey of a National Referral Center and review of the literature.
无功能性垂体腺瘤的流行病学、临床表现和合并症是否存在性别差异?国家转诊中心的前瞻性调查及文献复习。
J Endocrinol Invest. 2021 May;44(5):957-968. doi: 10.1007/s40618-020-01379-2. Epub 2020 Sep 7.
4
A Case of Giant Pituitary Adenoma Associated with a Postoperative Mental Disorder That Ultimately Resulted in Bilateral Blindness.一例巨大垂体腺瘤伴术后精神障碍最终导致双眼失明的病例。
Case Rep Ophthalmol. 2020 Mar 4;11(1):92-99. doi: 10.1159/000506392. eCollection 2020 Jan-Apr.
5
SIRT1 (rs3740051) role in pituitary adenoma development.SIRT1(rs3740051)在垂体腺瘤发生中的作用。
BMC Med Genet. 2019 Nov 20;20(1):185. doi: 10.1186/s12881-019-0892-x.
6
Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma.现代分割放疗、当代立体定向放射外科及经蝶窦手术治疗无功能垂体大腺瘤的结果
J Clin Med. 2019 Apr 16;8(4):518. doi: 10.3390/jcm8040518.
7
Non-invasive radiomics approach potentially predicts non-functioning pituitary adenomas subtypes before surgery.非侵入性放射组学方法可能在手术前预测无功能垂体腺瘤亚型。
Eur Radiol. 2018 Sep;28(9):3692-3701. doi: 10.1007/s00330-017-5180-6. Epub 2018 Mar 23.
8
A novel "total pituitary hormone index" as an indicator of postoperative pituitary function in patients undergoing resection of pituitary adenomas.一种新型的“全垂体激素指数”作为垂体腺瘤切除患者术后垂体功能的指标。
Oncotarget. 2017 Mar 7;8(45):79111-79125. doi: 10.18632/oncotarget.15978. eCollection 2017 Oct 3.
9
Functional Outcome Changes in Surgery for Pituitary Adenomas After Intraoperative Occurrence of the Trigeminocardiac Reflex: First Description in a Retrospective Observational Study.垂体腺瘤手术中发生三叉神经心脏反射后的功能结局变化:一项回顾性观察研究中的首次描述
Medicine (Baltimore). 2015 Sep;94(37):e1463. doi: 10.1097/MD.0000000000001463.
10
Invasive adenoma and pituitary carcinoma: a SEER database analysis.侵袭性腺瘤和垂体癌:SEER 数据库分析。
Neurosurg Rev. 2014 Apr;37(2):279-85; discussion 285-6. doi: 10.1007/s10143-014-0525-y. Epub 2014 Feb 14.